Living Organ Donor Recovery Enhancement Program (NCT03865264) | Clinical Trial Compass
TerminatedNot Applicable
Living Organ Donor Recovery Enhancement Program
Stopped: study lost funding
United States21 participantsStarted 2017-04-20
Plain-language summary
The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Ages ≥ 18 years
. Cleared by a physician to participate in an exercise program
. Approved for evaluation to be a living liver or kidney donor
. Subjects willing and able to comply with the protocol procedures for the duration of the study, including the exercise regimen and scheduled follow-up visits
. Subjects who have given IRB-approved written informed consent, prior to any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the patient at any time without prejudice to future medical care
Exclusion criteria
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
RAND SF-36 questionnaires
Timeframe: From day of enrollment in the study (at least 4 weeks before surgery) up to 1 day prior to hepatectomy.
2
Level of pain experienced daily
Timeframe: From day of admission into ICU (post-hepatectomy) up to day of hospital discharge (4-14 days post-hepatectomy)
3
Duration in ICU
Timeframe: From day admission into ICU up to day of discharge to hospital floor or 14 days post hepatectomy, whichever came first.
4
Opioid usage
Timeframe: From day of hospital discharge (post-hepatectomy) up to 1 year post hepatectomy.
5
RAND SF-36 questionnaires
Timeframe: From month 1 to month 12 post transplantation.
6
Duration to return of daily activities
Timeframe: From day of hospital discharge to 1 year follow up.
7
Incidence of Post-operative hospital re-admissions